Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial
- PMID: 9308941
- DOI: 10.1016/s0360-3016(97)00333-7
Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial
Abstract
Purpose: The objective of this study was to determine whether the thermal dose delivered during hyperthermia treatments and other thermal factors correlate with outcome after combined radiation and hyperthermia of breast carcinoma recurrences. Data were from the combined hyperthermia and radiation treatment arms of four Phase III trials, which when pooled together, demonstrated a positive effect of hyperthermia.
Methods and materials: Four Phase III trials addressing the question of whether hyperthermia could improve the local response of superficial recurrent breast cancer to radiation therapy were combined into a single analysis. Thermal dosimetry data were collected from 120 of the 148 breast cancer recurrence patients who received hyperthermia. The data were analyzed for correlations between thermal parameters as well as important clinical parameters and outcome (complete response rate, local disease free survival, time to local failure, and overall survival).
Results: Five thermal parameters were tested, all associated with the low regions of the measured temperature distributions. Max(TDmin) and Sum(TDmin) were associated with complete response where TDmin is the minimum thermal dose measured by any of the tumor temperature sensors during a treatment: Max(TDmin) is the maximum of TDmin over a series of treatments. Using a categorical relationship with a cutoff of 10 min for Sum(TDmin), the complete response rate was 77% for Sum(TDmin) > 10 min and 43% for Sum(TDmin) < or = 10 min (p = 0.022, adjusted for study center and significant clinical factors). The overall complete response rate for hyperthermia and radiation was 61% compared to 41% for radiation alone. Either Max(TDmin) or Sum(TDmin) were also associated with local disease free survival, time to local failure and overall survival.
Conclusions: An earlier report of this trial demonstrated a significant benefit when hyperthermia was added to radiation in the treatment of breast cancer recurrences. The analysis of thermal factors demonstrates that parameters representative of the low end of the measured temperature distributions are associated with initial complete response rate, local disease-free survival, time to local failure and overall survival.
Similar articles
-
Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast.Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):887-99. doi: 10.1016/0360-3016(95)00212-4. Int J Radiat Oncol Biol Phys. 1995. PMID: 7591899
-
Thermoradiotherapy for residual microscopic cancer: elective or post-excisional hyperthermia and radiation therapy in the management of local-regional recurrent breast cancer.Int J Radiat Oncol Biol Phys. 1992;24(2):261-77. doi: 10.1016/0360-3016(92)90681-7. Int J Radiat Oncol Biol Phys. 1992. PMID: 1526865
-
Multiple field hyperthermia combined with radiotherapy in advanced carcinoma of the breast.Int J Hyperthermia. 1994 Sep-Oct;10(5):587-603. doi: 10.3109/02656739409022440. Int J Hyperthermia. 1994. PMID: 7806917
-
Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: a systematic review.Int J Hyperthermia. 2019;36(1):1024-1039. doi: 10.1080/02656736.2019.1665718. Int J Hyperthermia. 2019. PMID: 31621437
-
Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data.Int J Hyperthermia. 2010;26(7):612-7. doi: 10.3109/02656736.2010.487194. Int J Hyperthermia. 2010. PMID: 20849256 Free PMC article. Review.
Cited by
-
Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer.Mol Clin Oncol. 2021 May;14(5):103. doi: 10.3892/mco.2021.2265. Epub 2021 Mar 17. Mol Clin Oncol. 2021. PMID: 33796292 Free PMC article.
-
Procedure for creating a three-dimensional (3D) model for superficial hyperthermia treatment planning.Strahlenther Onkol. 2011 Dec;187(12):835-41. doi: 10.1007/s00066-011-2272-0. Epub 2011 Nov 25. Strahlenther Onkol. 2011. PMID: 22127361
-
Quo Vadis Oncological Hyperthermia (2020)?Front Oncol. 2020 Sep 4;10:1690. doi: 10.3389/fonc.2020.01690. eCollection 2020. Front Oncol. 2020. PMID: 33014841 Free PMC article. Review.
-
Open-source, small-animal magnetic resonance-guided focused ultrasound system.J Ther Ultrasound. 2016 Sep 5;4(1):22. doi: 10.1186/s40349-016-0066-7. eCollection 2016. J Ther Ultrasound. 2016. PMID: 27597889 Free PMC article.
-
MR thermometry characterization of a hyperthermia ultrasound array designed using the k-space computational method.Biomed Eng Online. 2006 Oct 25;5:56. doi: 10.1186/1475-925X-5-56. Biomed Eng Online. 2006. PMID: 17064421 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical